ADAMTS13 and COVID-19: Unlike this study, recent research showed that the reduction in the concentration of the ADAMTS13 protein causes thrombus and a reduction, albeit highly variable, in the number of platelets, being ADAMTS13 deficiency associated with a greater risk of mortality during hospitalization of patients with COVID-19 (Tiscia et al., 2020[70]).